The Global Challenge of Personalized Medicines

Andrew Stainthorpe, PhD
Video Categories: Personalized Medicine

Dr. Stainthorpe explains that when it comes to bringing personalized medicines to fruition, the challenge is the same worldwide. It is an effort that requires better understanding of disease pathways and markers as well as improved diagnostics.
November 10, 2012

PMO Interview with the Innovator Series: Volume 1

Deborah Dunsire, MD, President and CEO of Millennium: The Takeda Oncology Company, and Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation, discuss the issues and vision in improving personalized medicine strategies for patients with multiple myeloma.Deborah Dunsire, MD, is the former President and CEO of Millennium Pharmaceuticals, [ Read More ]

September 2, 2015

Challenges with Oral Oncolytics

Dixie-Lee Esseltine, MD and George Mulligan, PhD address the challenges that they foresee for patients as more oral oncolytics are developed.